LON:CTICathay International Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cathay International Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 1.15 0.00 (0.00 %) (As of 07/9/2020 04:00 PM ET) Add Compare Share Today's Range 1.15Now: GBX 1.15▼ 1.1550-Day Range 1.15MA: GBX 1.49▼ 252-Week Range 0.01Now: GBX 1.15▼ 3.43VolumeN/AAverage Volume28,138 shsMarket Capitalization£22.01 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Cathay International Holdings Limited, an investment holding company, invests and operates in the healthcare sector in the People's Republic of China. It operates through five segments: Lansen, Haizi, Natural Dailyhealth, Botai, and Hotel Operations. The Lansen segment manufactures, markets, and sells pharmaceuticals, cosmeceutical products, plant extracts, and healthcare products. This segment focuses on the rheumatic specialty prescription western pharmaceuticals for the treatment of autoimmune rheumatic diseases and dermatology indications; develops, manufactures, and distributes rheumatic drugs; and sells diagnostic kits and cosmeceutical products. The Haizi segment manufactures, markets, and sells inositol and phosphate related products. The Natural Dailyhealth segment provides plant extracts, such as bilberry, ginkgo extract, and ginseng extract for use as ingredients in health products. The Botai segment produces and sells collagen injectable fillers; and develops collagen related products. The Hotel Operations segment owns and operates The Crowne Plaza Hotel and Suites Landmark Shenzhen, a 5-star hotel located in the Lowu district of Shenzhen in the People's Republic of China. This segment's hotel consists of 312 rooms and suites, and banquet and meeting facilities. Cathay International Holdings Limited is based in Central, Hong Kong.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cathay International. Previous Next 2.6 Community Rank Outperform VotesCathay International has received 89 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCathay International has received 82 “underperform” votes. (Add your “underperform” vote.)Community SentimentCathay International has received 52.05% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cathay International and other stocks. Vote “Outperform” if you believe CTI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CTI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCathay International does not currently pay a dividend.Dividend GrowthCathay International does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cathay International insiders have not sold or bought any company stock. Previous Next 1.4 Earnings and Valuation Earnings GrowthEarnings for Cathay International are expected to grow in the coming year, from GBX (0.01) to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cathay International is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCathay International has a P/B Ratio of 0.09. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.4 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.81 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorN/A Current SymbolLON:CTI Previous Symbol CUSIPN/A CIKN/A Webwww.cathay-intl.com.hk Phone+85228289289Debt Debt-to-Equity Ratio209.71 Current Ratio0.66 Quick Ratio0.38Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£79.76 million Price / Sales0.28 Cash FlowGBX 6.70 per share Price / Cash Flow0.17 Book ValueGBX 12.30 per share Price / Book0.09Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,461 Outstanding Shares1,913,810,048Market Cap£22.01 million Next Earnings DateN/A OptionableNot Optionable LSE:CTI Rates by TradingView Receive CTI News and Ratings via Email Sign-up to receive the latest news and ratings for CTI and its competitors with MarketBeat's FREE daily newsletter. Cathay International (LON:CTI) Frequently Asked Questions How has Cathay International's stock been impacted by COVID-19 (Coronavirus)? Cathay International's stock was trading at GBX 0.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CTI shares have increased by 6,116.2% and is now trading at GBX 1.15. View which stocks have been most impacted by Coronavirus. Has Cathay International been receiving favorable news coverage? Media stories about CTI stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cathay International earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news about Cathay International. Who are some of Cathay International's key competitors? Some companies that are related to Cathay International include Futura Medical (FUM), Vita Life Sciences (VLS), Pharmaxis (PXS), Antisense Therapeutics (ANP), China Pharma (CPHI), Avivagen (VIV), Sareum (SAR), Patrys (PAB), N4 Pharma (N4P), Bayer (BAYN), HedgePath Pharmaceuticals (MAYNF), OTSUKA HOLDINGS/ADR (OTSKY), Roche (RHHVF), Sanofi (SNYNF) and Sanofi (SAN). View all competitors. Who are Cathay International's key executives? Cathay International's management team includes the following people: Mr. Ka Chi Siu, Fin. Director & Director (Age 57, Pay $265k)Mr. Patrick Sung, Controller & Director (Age 58, Pay $228k)Ms. Xuezi Liu, VP & Co-Head of Asset Management (Age 43)Mr. Chi-Hung Yiu, Company Sec. (Age 28) What is Cathay International's stock symbol? Cathay International trades on the London Stock Exchange (LON) under the ticker symbol "CTI." How do I buy shares of Cathay International? Shares of CTI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Cathay International's stock price today? One share of CTI stock can currently be purchased for approximately GBX 1.15. How big of a company is Cathay International? Cathay International has a market capitalization of £22.01 million and generates £79.76 million in revenue each year. Cathay International employs 1,461 workers across the globe. What is Cathay International's official website? The official website for Cathay International is www.cathay-intl.com.hk. How can I contact Cathay International? Cathay International's mailing address is Suites 1203-4, 12/F, Li Po Chun Chambers 189 Des Voeux Road Central, Hong Kong,, Hong Kong. The company can be reached via phone at +85228289289. This page was last updated on 7/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
